FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and aims at normalising antioxidant blood system activity. In acute immobilisation stress, breast region is exposed to tetra-hertz waves at molecular nitrogen oxide radiation and absorption spectrum frequencies 150,176-150,664 GHz and power density ~0.2 mWt/cm2 during 30 minutes.
EFFECT: method allows normalising antioxidant blood system activity in experimental environment.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF NORMALISING ALTERED INDICES OF METABOLIC STATUS IN EXPERIMENT | 2010 |
|
RU2432974C1 |
METHOD OF NORMALISING DISTURBED CAPACITY OF THYROID GLAND IN EXPERIMENT | 2009 |
|
RU2392984C1 |
METHOD FOR NORMALISING ABNORMAL BLOOD NITRITE CONCENTRATION | 2010 |
|
RU2414937C1 |
METHOD OF LOWERED CONCENTRATION OF NITRITES IN BLOOD PLASMA IN CONDITIONS OF STRESS RESTORATION | 2007 |
|
RU2342961C1 |
METHOD OF STRESS DISTURBANCE NORMALISATION IN BLOOD RHEOLOGY IN VIVO IN EXPERIMENT | 2009 |
|
RU2398606C1 |
METHOD OF IMPAIRED FUNCTIONAL ACTIVITY CORRECTION FOR GLYCOPROTEID THROMBOCYTE RECEPTORS | 2007 |
|
RU2371215C2 |
METHOD OF DECREASING BLOOD CATECHOLAMINE CONCENTRATION IN STRESS CONDITIONS | 2008 |
|
RU2396993C2 |
METHOD OF CORRECTING DISTURBED FUNCTIONAL ACTIVITY OF GLYCOPROTEIN RECEPTORS OF ERYTHROCYTES | 2009 |
|
RU2394611C1 |
METHOD OF LIPID PEROXIDATION CORRECTION IN EXPERIMENT | 2008 |
|
RU2393891C1 |
METHOD OF DECREASING BLOOD CORTICOTROPHIN CONCENTRATION UNDER STRESS | 2009 |
|
RU2398604C1 |
Authors
Dates
2010-04-20—Published
2008-12-29—Filed